FR2310764A1 - ORAL-ADMINISTERED SOLID DRUG FORMS OF WATER-SOLUBLE XANTHINE DERIVATIVES - Google Patents

ORAL-ADMINISTERED SOLID DRUG FORMS OF WATER-SOLUBLE XANTHINE DERIVATIVES

Info

Publication number
FR2310764A1
FR2310764A1 FR7613720A FR7613720A FR2310764A1 FR 2310764 A1 FR2310764 A1 FR 2310764A1 FR 7613720 A FR7613720 A FR 7613720A FR 7613720 A FR7613720 A FR 7613720A FR 2310764 A1 FR2310764 A1 FR 2310764A1
Authority
FR
France
Prior art keywords
oral
water
solid drug
xanthine derivatives
drug forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7613720A
Other languages
French (fr)
Other versions
FR2310764B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2310764A1 publication Critical patent/FR2310764A1/en
Application granted granted Critical
Publication of FR2310764B1 publication Critical patent/FR2310764B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7613720A 1975-05-10 1976-05-07 ORAL-ADMINISTERED SOLID DRUG FORMS OF WATER-SOLUBLE XANTHINE DERIVATIVES Granted FR2310764A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2520978A DE2520978C3 (en) 1975-05-10 1975-05-10 Dosage unit of a solid, orally administered drug form of water-soluble xanthine derivatives

Publications (2)

Publication Number Publication Date
FR2310764A1 true FR2310764A1 (en) 1976-12-10
FR2310764B1 FR2310764B1 (en) 1980-07-11

Family

ID=5946306

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7613720A Granted FR2310764A1 (en) 1975-05-10 1976-05-07 ORAL-ADMINISTERED SOLID DRUG FORMS OF WATER-SOLUBLE XANTHINE DERIVATIVES

Country Status (12)

Country Link
US (1) US4189469A (en)
AU (1) AU502644B2 (en)
BE (1) BE841617A (en)
CY (1) CY1153A (en)
DE (1) DE2520978C3 (en)
DK (1) DK153918C (en)
FR (1) FR2310764A1 (en)
GB (1) GB1547232A (en)
HK (1) HK42382A (en)
KE (1) KE3219A (en)
MY (1) MY8600617A (en)
ZA (1) ZA762748B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006627A1 (en) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Sustained release theophylline compositions and processes
EP0273005A1 (en) * 1986-11-27 1988-06-29 Zyma SA Water-dispersible tablet
EP0519820A1 (en) * 1991-06-18 1992-12-23 Adir Et Compagnie Matrixtablet for the sustained release of indapamide after oral administration

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491539A (en) * 1981-06-04 1985-01-01 The Procter & Gamble Company Liquid cleansing product with skin feel additives
DE3127237A1 (en) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt STOMACHICABLE MEDICINAL FORMS OF XANTHINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3508097A1 (en) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt COMBINATION PRODUCT MADE OF XANTHINE DERIVATIVES AND O-ACETYLSALICYL ACID OR THEIR PHARMACOLOGICALLY COMPATIBLE SALTS AND THE USE THEREOF
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5112827A (en) * 1990-05-18 1992-05-12 Board Of Regents, The University Of Texas System Drug to reverse fatty liver and atheromatous lesions
US5498802A (en) * 1995-02-28 1996-03-12 Hoechst Celanese Corporation Process for preparing omega-halo-ketones
US20040209900A1 (en) * 2003-04-15 2004-10-21 Hauptman Stephen P. Treatment of lipodystrophy (lipid redistribution syndrome)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1617418C3 (en) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Manufacture of solid drug forms with delayed release of active ingredients
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3639169A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006627A1 (en) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Sustained release theophylline compositions and processes
EP0273005A1 (en) * 1986-11-27 1988-06-29 Zyma SA Water-dispersible tablet
EP0519820A1 (en) * 1991-06-18 1992-12-23 Adir Et Compagnie Matrixtablet for the sustained release of indapamide after oral administration
FR2677886A1 (en) * 1991-06-18 1992-12-24 Adir MATRIX COMPRESSOR FOR PROLONGED INDAPAMIDE RELEASE AFTER ORAL ADMINISTRATION.

Also Published As

Publication number Publication date
ZA762748B (en) 1977-04-27
DK153918B (en) 1988-09-26
AU502644B2 (en) 1979-08-02
DK205376A (en) 1976-11-11
HK42382A (en) 1982-10-08
MY8600617A (en) 1986-12-31
FR2310764B1 (en) 1980-07-11
GB1547232A (en) 1979-06-06
DE2520978B2 (en) 1980-06-12
DE2520978C3 (en) 1981-02-19
BE841617A (en) 1976-11-08
US4189469A (en) 1980-02-19
DK153918C (en) 1989-02-06
CY1153A (en) 1982-09-10
AU1376576A (en) 1977-11-17
KE3219A (en) 1982-08-13
DE2520978A1 (en) 1976-11-18

Similar Documents

Publication Publication Date Title
NL7808125A (en) PHARMACEUTICAL PREPARATIONS OF ALUMINUM SALTS OF IBUPROPHENE.
NL7607159A (en) METHODS FOR THE PREPARATION AND USE OF PHENYLAIC ACID DERIVATIVES.
NL190812C (en) Process for the preparation of 1,4-dihydropyridine derivatives with vasodilating and hypotensive effects, and pharmaceutical preparations comprising these derivatives.
NL190721C (en) Process for the preparation of 3-hydroxy-cephem derivatives.
NL7605749A (en) PROCESS FOR THE PREPARATION OF 2,6-DIMETHYL-6-SUBSTITUATED HEPTANE DERIVATIVES.
FR2310764A1 (en) ORAL-ADMINISTERED SOLID DRUG FORMS OF WATER-SOLUBLE XANTHINE DERIVATIVES
NO141411C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ERYTHROMYCIN DERIVATIVES
NL7606120A (en) PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE HETEROARYL DERIVATIVES.
BE847044A (en) CLAVULANIC ACID DERIVATIVES,
MX3743E (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES 3,4-DIHIDRO-2 (LH) -QUINAZOLINONE
NL186162B (en) METHOD FOR THE PREPARATION OF ORGANOTITANATES AND FOR THE PREPARATION OF MIXTURES USING THESE ORGANOTITANATES
NL7807453A (en) HALOGEN METHYL DERIVATIVES OF ALPHA AMINO ACIDS.
NL7812600A (en) PROCESS FOR THE PREPARATION OF GUANIDINE DERIVATIVES.
BE838094A (en) PREPARATION OF WATER-SOLUBLE AZOIC COLORANTS
NL7606178A (en) PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE HETEROARYL DERIVATIVES.
NL7608297A (en) PROCESS FOR THE PREPARATION AND USE OF DERIVATIVES OF SUBSTITUTED N-ALKYLIMIDAZOLES.
NL7610059A (en) PROCESS FOR THE PREPARATION OF 4-OXO-4H-BENZO-PYRAND DERIVATIVES.
NL7707515A (en) PROCESS FOR THE PREPARATION OF CYANURIC ACID DERIVATIVES.
NL7613307A (en) PROCEDURE FOR PREPARING 2 (1H) -CHINAZO- LINON DERIVATIVES.
NL7605172A (en) PROCESS FOR THE PREPARATION OF 2- (2,2-DIHALO-NO-VINYL) -3,3-DIMETHYLCYCLOPROPANE-1-SUBSTITUATED DERIVATIVES.
NL7610057A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL7710336A (en) PROCESS FOR THE PREPARATION OF ANTHRACHINONE DERIVATIVES.
NL7604330A (en) PROCESS FOR THE PREPARATION OF 8-AZAPROSTAN ACID DERIVATIVES.
NO159273C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE BENZOTRIAZOL DERIVATIVES.
NL7613714A (en) TRIFLUORMETHYLDHIO DERIVATIVES OF CYPROHEPTADINE.